Form 4 for TNYA Tenaya Therapeutics, Inc.
Accepted 2021-08-04 00:00:00 ET · period of report 2021-08-03 · accession 0001209191-21-049759 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-04 | 2021-08-03 | TNYA | Kang JeenJoo | Dir | C - Cnv Deriv | $0.00 | +12.5K | 25.0K | +100% | $0 |
| D | 2021-08-04 | 2021-08-03 | TNYA | Kang JeenJoo | Dir | C - Cnv Deriv | — | -12.5K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-03 | C | A | 12,500 | $0.00 | 25,000 | D | — | — | (F1) Each share of Series A Preferred Stock automatically converted into one share of common stock immediately prior to the completion of the Issuer's initial public offering, and had no expiration date. |
| 2 | Derivative | Series A Preferred Stock | 2021-08-03 | C | D | 12,500 | — | 0 | D | $0.00 · — to — | 12,500 Common Stock | (F1) Each share of Series A Preferred Stock automatically converted into one share of common stock immediately prior to the completion of the Issuer's initial public offering, and had no expiration date. |